HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MSLE

Satellos Bioscience Inc

Last Close
Feb 06  •  04:00PM ET
11.25
Dollar change
-0.66
Percentage change
-5.54 %
Healthcare • Biotechnology • Canada • NASD
Held by: SURI
Scroll to Statements
Index- P/E- EPS (ttm)-1.57 Insider Own17.41% Shs Outstand15.42M Perf Week-3.29%
Market Cap173.93M Forward P/E- EPS next Y- Insider Trans- Shs Float12.77M Perf Month62.11%
Enterprise Value139.31M PEG- EPS next Q- Inst Own1.71% Short Float- Perf Quarter91.68%
Income-21.94M P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y129.61%
Sales0.00M P/B5.10 EPS next Y- ROA-79.16% Short Interest- Perf YTD91.33%
Book/sh2.20 P/C5.03 EPS next 5Y- ROE-89.10% 52W High- - Perf Year64.40%
Cash/sh2.24 P/FCF- EPS past 3/5Y29.67% 5.62% ROIC-64.52% 52W Low- - Perf 3Y-20.28%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility5.53% 10.40% Perf 5Y46.94%
Dividend TTM- EV/Sales- EPS Y/Y TTM29.54% Oper. Margin- ATR (14)0.86 Perf 10Y-
Dividend Ex-Date- Quick Ratio10.70 Sales Y/Y TTM- Profit Margin- RSI (14)65.83 Recom-
Dividend Gr. 3/5Y- - Current Ratio10.70 EPS Q/Q40.72% SMA200.00% Beta- Target Price-
Payout- Debt/Eq0.00 Sales Q/Q- SMA500.00% Rel Volume- Prev Close11.91
Employees14 LT Debt/Eq0.00 Earnings- SMA2000.00% Avg Volume14.35K Price11.25
IPOFeb 19, 2009 Option/ShortNo / No EPS/Sales Surpr.- - Trades Volume105,048 Change-5.54%
Feb-06-26 08:30AM
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
(Business Wire) -5.54%
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX and Leveraging MyoReGenX, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
open in yahoo | open in reuters | open in marketwatch | open in google
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.